Literature DB >> 7848287

The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes.

W R Pels Rijcken1, B Overdijk, D H Van den Eijnden, W Ferwerda.   

Abstract

Treatment of rat hepatocytes with 0.5 mM concentrations of uridine and cytidine results in increased cellular concentrations of UTP, UDP-sugars and CTP, whereas that of CMP-N-acetylneuraminate remained unchanged [Pels Rijcken, Overdijk, Van den Eijnden and Ferwerda (1993) Biochem. J. 293, 207-213]. The incorporation of radioactivity from 3H-labelled sugars into the cell-associated and secreted glycoconjugate fraction was influenced by these altered cellular concentrations of the nucleotides. For [3H]glucosamine, pretreatment with uridine resulted in a reduction of the glycosylation in both fractions. Increases in the secreted fractions were observed for fucose with both uridine and cytidine and for N-acetylglucosamine with uridine only. With [3H]N-acetylglucosamine, similar specific radioactivities for UDP-N-acetylhexosamine and CMP-N-acetylneuraminate were found, regardless of the pretreatment conditions. With [3H]N-acetylmannosamine, the specific radioactivity of CMP-N-acetylneuraminate showed an almost 2-fold increase on pretreatment. The latter increase did not result in an increased incorporation of radioactivity into the glycoconjugates. It was estimated that, in untreated cells, the ratio of radioactivity incorporated from [3H]glucosamine into glycoconjugate-bound N-acetylhexosamine and N-acetylneuraminate amounted to 2:3. In pretreated cells this ratio changed to approx. 2:1. Overall, the data show that pretreatment resulted in an increased incorporation of N-acetylhexosamine into cell-associated and secreted glycoconjugates, accompanied by a reduction in sialylation. It was concluded that an increased availability of UDP-N-acetylhexosamine caused the increased incorporation of N-acetylhexosamine. The elevated cytosolic level of UDP-N-acetylhexosamine (and of compounds like CMP) is suggested to impair the transport of CMP-acetylneuraminate to the Golgi, resulting in reduced sialylation. This study demonstrates that protein glycosylation can be regulated at the level of the availability of the various nucleotide-sugars in the Golgi lumen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7848287      PMCID: PMC1136339          DOI: 10.1042/bj3050865

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  THE FEEDBACK CONTROL OF SUGAR NUCLEOTIDE BIOSYNTHESIS IN LIVER.

Authors:  S KORNFELD; R KORNFELD; E F NEUFELD; P J O'BRIEN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  The subcellular localization of cytidine 5'-monophospho-N-acetylneuraminic acid synthetase in calf brain.

Authors:  D H van den Eijnden
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

3.  Purification and properties of UDP-N-acetylglucosamine 2'-epimerase from rat liver.

Authors:  K Kikuchi; S Tsuiki
Journal:  Biochim Biophys Acta       Date:  1973-11-15

4.  Nuclear cytidine 5'-monophosphosialic acid synthetase.

Authors:  E L Kean
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

Review 5.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Subcellular localization of sugar nucleotide synthetases.

Authors:  S W Coates; T Gurney; L W Sommers; M Yeh; C B Hirschberg
Journal:  J Biol Chem       Date:  1980-10-10       Impact factor: 5.157

7.  CMP-N-acetylneuraminic acid: isolation from and penetration into mouse liver microsomes.

Authors:  D J Carey; L W Sommers; C B Hirschberg
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

8.  Intralumenal pool and transport of CMP-N-acetylneuraminic acid, GDP-fucose and UDP-galactose. Study with plasma-membrane-permeabilized mouse thymocytes.

Authors:  R Cacan; R Cecchelli; B Hoflack; A Verbert
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

9.  Detection of beta-galactosyl(1 leads to 4)N-acetylglucosaminide alpha(2 leads to 3)-sialyltransferase activity in fetal calf liver and other tissues.

Authors:  D H Van den Eijnden; W E Schiphorst
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

10.  Study of the conversion of GDP-mannose into GDP-fucose in Nereids: a biochemical marker of oocyte maturation.

Authors:  P Bulet; B Hoflack; M Porchet; A Verbert
Journal:  Eur J Biochem       Date:  1984-10-15
View more
  11 in total

1.  Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.

Authors:  Nan Lin; Joaquina Mascarenhas; Natalie R Sealover; Henry J George; Jeanne Brooks; Kevin J Kayser; Brian Gau; Isil Yasa; Parastoo Azadi; Stephanie Archer-Hartmann
Journal:  Biotechnol Prog       Date:  2015-03-01

2.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 3.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

4.  Liver-specific increase of UTP and UDP-sugar concentrations in rats induced by dietary vitamin B6-deficiency and its relation to complex N-glycan structures of liver membrane-proteins.

Authors:  Agnes B Renner; Kathrin Rieger; Detlef Grunow; Martin Zimmermann-Kordmann; Martin Gohlke; Werner Reutter
Journal:  Glycoconj J       Date:  2007-06-19       Impact factor: 2.916

5.  Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells.

Authors:  S M Lawrence; K A Huddleston; N Tomiya; N Nguyen; Y C Lee; W F Vann; T A Coleman; M J Betenbaugh
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

6.  Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems.

Authors:  M Butler
Journal:  Cytotechnology       Date:  2006-06-09       Impact factor: 2.058

7.  Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells.

Authors:  Susan C Burleigh; Teun van de Laar; Corné J M Stroop; Wout M J van Grunsven; Niaobh O'Donoghue; Pauline M Rudd; Gavin P Davey
Journal:  BMC Biotechnol       Date:  2011-10-18       Impact factor: 2.563

8.  Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation.

Authors:  Philip M Jedrzejewski; Ioscani Jimenez del Val; Antony Constantinou; Anne Dell; Stuart M Haslam; Karen M Polizzi; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2014-03-14       Impact factor: 5.923

Review 9.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

Review 10.  Determinants of Glycosaminoglycan (GAG) Structure.

Authors:  Kristian Prydz
Journal:  Biomolecules       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.